I would hope that after Merck's problems with Vioxx you wouldn't say "And people wonder why there is so little faith in medicines!"
Gardasil, being a new vaccine I think bares worth watching and closer examination. I also don't know about the exact incremental benefit that it offers. But, I'd also like to see some back-up to what Dr. Harper had to say on the matter.
However, I did notice a couple of things about the article:This comment by the author of the story is just plain silly. There's no basis to believe that their will just be a continual linear reduction of the number of cervical cancer cases over 60 years until they become extinguished totally. Instead, you can expect that as some point the reductions will slow and then likely reach a "floor" somewhere above zero unless there is some other medical breakthrough.
Scary stuff, I must say! However, the VAERS system is a self-reporting system where anyone can file a report of anything that happened that they think might be connected to the vaccine. If two weeks after I get a shot and I forget my wallet on my way to work, I can fill out a report with the VAERS system that I think that the vaccine triggered "memory loss". Bingo, by law it has to go into the system as I report it. And reporters and critics can use it to imply that the vaccine causes memory loss and some people "learn the hard way" about it by not being able to buy lunch at work.
But of course "dropping dead" is a pretty definite result and is a lot worse than having to bum $10 off of a co-worker. Dr. Harper's concern of the lack of pre-approval testing may be genuine, but it's good for us that the CDC and FDA performs periodic postlicensure safety surveillance studies on vaccines and drugs. These studies use reported "adverse events" in the VAERS and other adverse reporting systems, and compare these results with the rates of like events in the normal population. In August 2009, the results of the first postlicensure safety surveillance study of Gardasil were published in the JAMA. The study covers adverse events reported from June, 2006 to the end of 2008. During that time over 23 million doses of the vaccine where administered. The summary
is posted here. The findings? With the exceptions of "syncope" (fainting, 8.2 reports per 100,000 doses) and "venous thromboembolic" (blood clots within the blood vessels , 1 report per 500,000 doses), the rates of all other events (including "death") were at or below the levels you'd expect to normally see in that population size over that period of time. This is a government study, using government data... but to be safe they also included adverse reports from pre-licensing studies too.
There will be more surveillance studies over time, and you can bet that they'll be watching the clot issue more closely. The reported rate was above average for what you'd expect, but apparently not high enough to be a "smoking gun". As more doses are given, we'll see if problems are confirmed (or if they fad back to expected levels) or if new things about the vaccine emerge. But based on what's been seen so far, I think that those that are hoping the vaccine will be declared "unsafe" and pulled off the market will be disappointed by the data.
As for us, we gave it to our daughter. One of my wife's cousins also died of cervical cancer as a teenager.